knowledge -WSS

knowledge

author：entertainment 2025-10-01 21:47:39 - browse：5

Feng Zhang Editas — Aera was formed to pursue a nanoparticle described by Feng Zhang in 2021. Susan Walsh/AP

Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang last year to solve one of the biggest bottlenecks in genetic medicine, has laid off a quarter of its staff, the company confirmed to STAT.

The layoffs come as the biotech market remains mired in a now nearly three-year-long downturn that has left startups struggling to attract both private and public funds. Aera attributed the layoffs to those headwinds and indicated it had axed a portion of the company dedicated to developing new gene-editing enzymes.

“In 2023, Aera launched to pursue an ambitious mission to develop transformative genetic medicines by harnessing enabling delivery technologies and precision payloads,” spokesman Dan Budwick said in a statement. “Although Aera remains in a strong cash position today, given the current biotech funding environment, we have chosen to take steps to focus our strategy and investments on the development of our novel delivery platforms, thereby further extending our cash runway.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： WHO recommends second malaria vaccine

hotspot

explore

WSS

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

A disappointing year of Humira biosimilars

Robert F. Kennedy is pitching centrism on health, even on abortion

Industry veterans launch new biotech VC with $310M

What should King Charles tell the public about his cancer?

European officials brace for rough respiratory virus season

knowledge

knowledge

entertainment

Moonlake's readout produced a cash windfall. Risks remain

Industry veterans launch new biotech VC with $310M

ChatGPT in medicine: STAT answers readers' burning questions

Readout LOUD podcast: How biotech is using artificial intelligence

Supreme Court strikes down use of affirmative action

Readout LOUD podcast: How biotech is using artificial intelligence

Tori Bowie and the unacceptable rates of Black maternal death

KalVista pill reduced swelling 'attacks' caused by genetic disease

Affirmative action in medical school literally saved lives

Why did Pfizer dish out millions for a Super Bowl ad?

entertainment

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

European officials brace for rough respiratory virus season

CRISPR base editing slashes cholesterol levels in monkeys

RSV injection headlines need to be accurate for good uptake

6 solutions to address cancer drug shortages and others

hotspot

explore

Wikipedia

leisure time